Automated MR-based lung volume segmentation in population-based whole-body MR imaging: correlation with clinical characteristics, pulmonary function testing and obstructive lung disease
暂无分享,去创建一个
A. Peters | T. Ivanovska | S. Karrasch | H. Schulz | F. Bamberg | R. Lorbeer | C. Schlett | Jan Mueller | A. Pomschar | W. Kunz | R. von Krüchten | A. Peters
[1] Chin-Chou Wang,et al. Impact of overweight and obesity on acute exacerbations of COPD – subgroup analysis of the Taiwan Obstructive Lung Disease cohort , 2017, International journal of chronic obstructive pulmonary disease.
[2] T. H. Nguyen,et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Respiratory medicine.
[3] H. Watz,et al. Chronic obstructive pulmonary disease , 2017, The Lancet.
[4] J. Wedzicha,et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.
[5] Tahreema N. Matin,et al. Chronic Obstructive Pulmonary Disease: Lobar Analysis with Hyperpolarized 129Xe MR Imaging. , 2017, Radiology.
[6] J. Wedzicha,et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.
[7] E. Marchiori,et al. Whole-body MRI in pediatric patients with cancer , 2017, Cancer Imaging.
[8] V. Brusasco,et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung , 2017, European Respiratory Journal.
[9] M. Bottai,et al. Body height as risk factor for emphysema in COPD , 2016, Scientific Reports.
[10] W. Rathmann,et al. Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study , 2016, Diabetes.
[11] H. Kauczor,et al. Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imaging , 2016, Pediatric pulmonology.
[12] L. Fayad,et al. Current whole-body MRI applications in the neurofibromatoses , 2016, Neurology.
[13] M. Reiser,et al. Population-Based Imaging and Radiomics: Rationale and Perspective of the German National Cohort MRI Study , 2016, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
[14] F. Lecouvet. Whole-Body MR Imaging: Musculoskeletal Applications. , 2016, Radiology.
[15] J. Seo,et al. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease , 2015, Journal of Korean medical science.
[16] N. Michoux,et al. The Increasing Spectrum of Indications of Whole-Body MRI Beyond Oncology: Imaging Answers to Clinical Needs , 2015, Seminars in Musculoskeletal Radiology.
[17] J. Linseisen,et al. Whole-Body MR Imaging in the German National Cohort: Rationale, Design, and Technical Background. , 2015, Radiology.
[18] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[19] Wei Zhang,et al. Lung Volume Change After Pedicle Subtraction Osteotomy in Patients With Ankylosing Spondylitis With Thoracolumbar Kyphosis , 2015, Spine.
[20] B. Hamm,et al. Automated lung volumetry from routine thoracic CT scans: how reliable is the result? , 2014, Academic radiology.
[21] M. Kersten,et al. Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET , 2013, European Radiology.
[22] S. Stanojevic,et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.
[23] M. Puderbach,et al. MRI of the lung (1/3): methods , 2012, Insights into Imaging.
[24] Katrin Hegenscheid,et al. A fast and accurate automatic lung segmentation and volumetry method for MR data used in epidemiological studies , 2012, Comput. Medical Imaging Graph..
[25] David Price,et al. Spirometry: an essential tool for screening, case-finding, and diagnosis of COPD. , 2012, Primary care respiratory journal : journal of the General Practice Airways Group.
[26] M. Puderbach,et al. MRI of the lung (2/3). Why … when … how? , 2012, Insights into Imaging.
[27] G. Beluffi,et al. MRI of the lung , 2010, La radiologia medica.
[28] P. Jones,et al. Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.
[29] P. Leander,et al. Validity of apparent diffusion coefficient hyperpolarized 3He-MRI using MSCT and pulmonary function tests as references. , 2009, European journal of radiology.
[30] S. Ladd. Whole-body MRI as a screening tool? , 2009, European journal of radiology.
[31] Wim Timens,et al. The pathology of chronic obstructive pulmonary disease. , 2009, Annual review of pathology.
[32] C. Jenkins. COPD management. Part I. Strategies for managing the burden of established COPD. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[33] K. Larsson,et al. Low awareness of COPD among physicians , 2008, The clinical respiratory journal.
[34] J. Hankinson,et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.
[35] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[36] R Holle,et al. KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
[37] J. Hankinson,et al. General considerations for lung function testing , 2005, European Respiratory Journal.
[38] S. Guerra,et al. The relation of body mass index to asthma, chronic bronchitis, and emphysema. , 2002, Chest.
[39] S. Rennard,et al. COPD in 2001: a major challenge for medicine, the pharmaceutical industry, and society. , 2002, Chest.
[40] T. Gotoh,et al. Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema , 2002, European Respiratory Journal.
[41] K. Esato,et al. Interactions of regional respiratory mechanics and pulmonary ventilatory impairment in pulmonary emphysema: assessment with dynamic MRI and xenon-133 single-photon emission CT. , 2000, Chest.
[42] K. Suga,et al. Respiratory failure and pulmonary hypertension associated with Klippel-Feil syndrome , 1999, Annals of nuclear medicine.
[43] M Thelen,et al. Assessment of lung volumes using helical CT at inspiration and expiration: comparison with pulmonary function tests. , 1998, AJR. American journal of roentgenology.
[44] T. Petty,et al. Screening and early intervention for COPD. , 1998, Hospital practice.
[45] R M Slone,et al. MR analysis of lung volume and thoracic dimensions in patients with emphysema before and after lung volume reduction surgery. , 1998, AJR. American journal of roentgenology.
[46] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[47] S. Doğan,et al. MRI of pneumonia in immunocompromised patients: comparison with CT. , 2017, Diagnostic and interventional radiology.
[48] E. Ford,et al. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. , 2015, Chest.
[49] James T.C. Li,et al. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. , 2015, Allergy and asthma proceedings.
[50] T Hielscher,et al. Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance , 2014, Leukemia.